BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16724546)

  • 21. Unusual dimeric chemical structure for a carboplatin analogue as a potential anticancer complex.
    Xie M; Liu W; Lou L; Chen X; Ye Q; Yu Y; Chang Q; Hou S
    Inorg Chem; 2010 Jul; 49(13):5792-4. PubMed ID: 20515022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
    Grabner S; Modec B; Cemazar M; Bukovec N
    J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New water-soluble platinum(II) phenanthroline complexes tested as cisplatin analogues: First-time comparison of cytotoxic activity between analogous four- and five-coordinate species.
    De Pascali SA; Migoni D; Papadia P; Muscella A; Marsigliante S; Ciccarese A; Fanizzi FP
    Dalton Trans; 2006 Nov; (42):5077-87. PubMed ID: 17060994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atropisomerization, C-H activation, and dissociative substitution at some biphenyl platinum(II) complexes.
    Plutino MR; Scolaro LM; Albinati A; Romeo R
    J Am Chem Soc; 2004 May; 126(20):6470-84. PubMed ID: 15149244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
    Matesanz AI; Joie C; Souza P
    Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-heterocyclic carbene-amine Pt(II) complexes, a new chemical space for the development of platinum-based anticancer drugs.
    Skander M; Retailleau P; Bourrié B; Schio L; Mailliet P; Marinetti A
    J Med Chem; 2010 Mar; 53(5):2146-54. PubMed ID: 20148592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and biological properties of a new cis-diammineplatinum (II) complex containing para-aminobenzoic acid as amino ligand.
    Parodi B; Esposito M; Viale M; Cafaggi S; Vannozzi M
    Anticancer Res; 1995; 15(3):895-9. PubMed ID: 7645978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
    Mishur RJ; Zheng C; Gilbert TM; Bose RN
    Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization, DNA binding, and in vitro cytotoxicity of the enantiomers of the platinum(II) complexes N-methyl-, N-ethyl- and N,N-dimethyl-(R)- and -(S)-3-aminohexahydroazepinedichloroplatinum(II).
    Rezler EM; Fenton RR; Esdale WJ; McKeage MJ; Russell PJ; Hambley TW
    J Med Chem; 1997 Oct; 40(22):3508-15. PubMed ID: 9357517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
    Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK
    Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
    Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.